Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Community
/
United States
/
Healthcare
/
Electromed
ELMD
Electromed
Concentrated Respiratory Care Will Face Hurdles While Sustaining Modest Promise
AN
AnalystLowTarget
Not Invested
Consensus Narrative from 3 Analysts
Published
27 Jul 25
Updated
16 Aug 25
0
Set Fair Value
0
votes
Share
AnalystLowTarget
's Fair Value
US$29.00
34.7% undervalued
intrinsic discount
16 Aug
US$18.93
Loading
1Y
28.2%
7D
-1.1%
Author's Valuation
US$29.0
34.7% undervalued
intrinsic discount
AnalystLowTarget Fair Value
View Valuation
Narrative
Updates
0
Valuator
Company Info
Notes
AnalystLowTarget Fair Value
US$29.0
34.7% undervalued
intrinsic discount
Future estimation in
3 Years
time period
Past
Future
-576k
86m
2014
2017
2020
2023
2025
2026
2028
Revenue US$85.5m
Earnings US$10.3m
Revenue
Profit Margin
Future PE
Revenue
% p.a.
0
Decrease
Increase
Current revenue growth rate
6.56%
Medical Equipment revenue growth rate
0.45%
Other Inputs & Calculation
Risk Level (Discount Rate)
Our default considers factors like the company's size, volatility, profitablity and country of operation.
Risk Level (Discount Rate)
%
0
Decrease
Increase
Current discount rate
7.47%
Calculation
US$10.26m
Earnings '28
x
26.93x
PE Ratio '28
=
US$276.16m
Market Cap '28
US$276.16m
Market Cap '28
/
7.67m
No. shares '28
=
US$36.00
Share Price '28
US$36.00
Share Price '28
Discounted to 2025 @ 7.47% p.a.
=
US$29.00
Fair Value '25
